Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT07044115
What this trial is testing

Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis

Who this might be right for
Lupus Nephritis
Beijing Mabworks Biotech Co., Ltd. 41
Not applicableNot Yet RecruitingNCT07837544
What this trial is testing

Diastolic Dysfunction and Inflammatory Biomarkers in Lupus Nephritis

Who this might be right for
Lupus NephritisDiastolic DysfunctionSystemic Lupus Erythematosus+1 more
Assiut University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07785128
What this trial is testing

Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Shaheed Suhrawardy Medical College and Hospital 104
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Testing effectiveness (Phase 2)Study completedNCT00004448
What this trial is testing

Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy

Who this might be right for
IgA Glomerulonephritis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 96
Large-scale testing (Phase 3)Ended earlyNCT02647255
What this trial is testing

Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAKidney DiseasesAcute Renal Insufficiency+1 more
Peking University First Hospital 10
Not applicableLooking for participantsNCT05190848
What this trial is testing

Correlation of Microbiome and Metabonomics With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 600
Not applicableNot Yet RecruitingNCT07130448
What this trial is testing

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)SLE - Systemic Lupus ErythematosusBiomarkers
Assiut University 120
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)UnknownNCT01539902
What this trial is testing

Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
CytoMed & Beike 25
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Post-approval studies (Phase 4)UnknownNCT02571842
What this trial is testing

Rituximab in Recurrent IgA Nephropathy

Who this might be right for
Recurrent IgA Nephropathy
Chulalongkorn University 30
Large-scale testing (Phase 3)Looking for participantsNCT06904729
What this trial is testing

Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children

Who this might be right for
Lupus Nephritis
Guangzhou Women and Children's Medical Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07015983
What this trial is testing

CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Testing effectiveness (Phase 2)Looking for participantsNCT06797518
What this trial is testing

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Who this might be right for
Glomerulonephritis, IGAImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06982040
What this trial is testing

Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Nanjing Chia-tai Tianqing Pharmaceutical 80
Post-approval studies (Phase 4)Study completedNCT04424602
What this trial is testing

Comparison between2 Drugs in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Al-Azhar University 40
Not applicableStudy completedNCT00199628
What this trial is testing

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Who this might be right for
Glomerulonephritis, MembranousNeonatal Diseases and AbnormalitiesHemochromatosis
University Hospital, Limoges 100
Not applicableLooking for participantsNCT06631404
What this trial is testing

Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Sohag University 55
Next Page